Exploring the Controversial Concept of Chronic Lyme Disease
JUL 14, 2018 | CONTAGION® EDITORIAL STAFF
Segment Description: Samuel, Shor, MD, FACP, past president, International Lyme and Associated Diseases Society, explores the controversial concept of chronic Lyme disease and the role of antibiotic stewardship in treatment programs.
Interview Transcript (modified slightly for readability):
“The controversy in treating Lyme disease is particularly in relation to the concept of chronic Lyme disease, or that which involves active infection of the organism Borrelia burgdorferi that is responsible for perpetuation of ongoing symptoms for at least 6 months. There are 2 categories that I believe fit into this paradigm. One is those who never got diagnosed [and], in essence, are untreated—which is a large group—and the other is what’s characterized as post-treatment group.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Big advances in treatment can't make up for an inability to stop new infections, which number 5,000 per day worldwide.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512